-+ 0.00%
-+ 0.00%
-+ 0.00%

Novo Nordisk CEO: Wegovy tablets already account for about 90% of the oral obesity drug market.

Zhitongcaijing·08/05/2026 06:09:04
Listen to the news
Novo Nordisk CEO: Wegovy tablets already account for about 90% of the oral obesity drug market.